Skip to main content
NCBI home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2000 May;68(5):550–557. doi: 10.1136/jnnp.68.5.550

HTLV-1 and HIV infections of the central nervous system in tropical areas

P Cabre 1, D Smadja 1, A Cabie 1, C Newton 1
PMCID: PMC1736928  PMID: 10766881

Full Text

The Full Text of this article is available as a PDF (141.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anders K. H., Guerra W. F., Tomiyasu U., Verity M. A., Vinters H. V. The neuropathology of AIDS. UCLA experience and review. Am J Pathol. 1986 Sep;124(3):537–558. [PMC free article] [PubMed] [Google Scholar]
  2. Araújo A. Q., Leite A. C., Dultra S. V., Andrada-Serpa M. J. Progression of neurological disability in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). J Neurol Sci. 1995 Apr;129(2):147–151. doi: 10.1016/0022-510x(94)00266-q. [DOI] [PubMed] [Google Scholar]
  3. Araújo A. de Q., Alfonso C. R., Schor D., Leite A. C., de Andrada-Serpa M. J. Clinical and demographic features of HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Rio de Janeiro, Brazil. Acta Neurol Scand. 1993 Jul;88(1):59–62. doi: 10.1111/j.1600-0404.1993.tb04188.x. [DOI] [PubMed] [Google Scholar]
  4. Baqi M., Kucharczyk W., Walmsley S. L. Regression of progressive multifocal encephalopathy with highly active antiretroviral therapy. AIDS. 1997 Oct;11(12):1526–1527. [PubMed] [Google Scholar]
  5. Bartholomew C., Cleghorn F., Jack N., Edwards J., Blattner W. Human T-cell lymphotropic virus type I-associated facial nerve palsy in Trinidad and Tobago. Ann Neurol. 1997 Jun;41(6):806–809. doi: 10.1002/ana.410410617. [DOI] [PubMed] [Google Scholar]
  6. Bell J. E., Lowrie S., Koffi K., Hondé M., Andoh J., De Cock K. M., Lucas S. B. The neuropathology of HIV-infected African children in Abidjan, Côte d'Ivoire. J Neuropathol Exp Neurol. 1997 Jun;56(6):686–692. [PubMed] [Google Scholar]
  7. Berenguer J., Moreno S., Laguna F., Vicente T., Adrados M., Ortega A., González-LaHoz J., Bouza E. Tuberculous meningitis in patients infected with the human immunodeficiency virus. N Engl J Med. 1992 Mar 5;326(10):668–672. doi: 10.1056/NEJM199203053261004. [DOI] [PubMed] [Google Scholar]
  8. Bhigjee A. I., Kelbe C., Haribhai H. C., Windsor I. M., Hoffmann M. H., Modi G., Bill P. L., Becker W. B., Singh B., Engelbrecht S. Myelopathy associated with human T cell lymphotropic virus type I (HTLV-I) in natal, South Africa. A clinical and investigative study in 24 patients. Brain. 1990 Oct;113(Pt 5):1307–1320. doi: 10.1093/brain/113.5.1307. [DOI] [PubMed] [Google Scholar]
  9. Boivin M. J., Green S. D., Davies A. G., Giordani B., Mokili J. K., Cutting W. A. A preliminary evaluation of the cognitive and motor effects of pediatric HIV infection in Zairian children. Health Psychol. 1995 Jan;14(1):13–21. doi: 10.1037//0278-6133.14.1.13. [DOI] [PubMed] [Google Scholar]
  10. Boufassa F., Bachmeyer C., Carré N., Deveau C., Persoz A., Jadand C., Séréni D., Bucquet D. Influence of neurologic manifestations of primary human immunodeficiency virus infection on disease progression. SEROCO Study Group. J Infect Dis. 1995 May;171(5):1190–1195. doi: 10.1093/infdis/171.5.1190. [DOI] [PubMed] [Google Scholar]
  11. Brodt H. R., Kamps B. S., Gute P., Knupp B., Staszewski S., Helm E. B. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS. 1997 Nov 15;11(14):1731–1738. doi: 10.1097/00002030-199714000-00010. [DOI] [PubMed] [Google Scholar]
  12. Burns D. K. The neuropathology of pediatric acquired immunodeficiency syndrome. J Child Neurol. 1992 Oct;7(4):332–346. doi: 10.1177/088307389200700402. [DOI] [PubMed] [Google Scholar]
  13. Canessa A., Del Bono V., De Leo P., Piersantelli N., Terragna A. Cotrimoxazole therapy of Toxoplasma gondii encephalitis in AIDS patients. Eur J Clin Microbiol Infect Dis. 1992 Feb;11(2):125–130. doi: 10.1007/BF01967063. [DOI] [PubMed] [Google Scholar]
  14. Chimelli L., Rosemberg S., Hahn M. D., Lopes M. B., Netto M. B. Pathology of the central nervous system in patients infected with the human immunodeficiency virus (HIV): a report of 252 autopsy cases from Brazil. Neuropathol Appl Neurobiol. 1992 Oct;18(5):478–488. doi: 10.1111/j.1365-2990.1992.tb00815.x. [DOI] [PubMed] [Google Scholar]
  15. Chuck S. L., Sande M. A. Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med. 1989 Sep 21;321(12):794–799. doi: 10.1056/NEJM198909213211205. [DOI] [PubMed] [Google Scholar]
  16. Dolin P. J., Raviglione M. C., Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ. 1994;72(2):213–220. [PMC free article] [PubMed] [Google Scholar]
  17. Drotar D., Olness K., Wiznitzer M., Guay L., Marum L., Svilar G., Hom D., Fagan J. F., Ndugwa C., Kiziri-Mayengo R. Neurodevelopmental outcomes of Ugandan infants with human immunodeficiency virus type 1 infection. Pediatrics. 1997 Jul;100(1):E5–E5. doi: 10.1542/peds.100.1.e5. [DOI] [PubMed] [Google Scholar]
  18. Dubé M. P., Holtom P. D., Larsen R. A. Tuberculous meningitis in patients with and without human immunodeficiency virus infection. Am J Med. 1992 Nov;93(5):520–524. doi: 10.1016/0002-9343(92)90579-z. [DOI] [PubMed] [Google Scholar]
  19. Floeter M. K., Civitello L. A., Everett C. R., Dambrosia J., Luciano C. A. Peripheral neuropathy in children with HIV infection. Neurology. 1997 Jul;49(1):207–212. doi: 10.1212/wnl.49.1.207. [DOI] [PubMed] [Google Scholar]
  20. Gelbard H. A., Epstein L. G. HIV-1 encephalopathy in children. Curr Opin Pediatr. 1995 Dec;7(6):655–662. doi: 10.1097/00008480-199512000-00005. [DOI] [PubMed] [Google Scholar]
  21. Gessain A., Barin F., Vernant J. C., Gout O., Maurs L., Calender A., de Thé G. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985 Aug 24;2(8452):407–410. doi: 10.1016/s0140-6736(85)92734-5. [DOI] [PubMed] [Google Scholar]
  22. Gessain A., Caudie C., Gout O., Vernant J. C., Maurs L., Giordano C., Malone G., Tournier-Lasserve E., Essex M., de-Thé G. Intrathecal synthesis of antibodies to human T lymphotropic virus type I and the presence of IgG oligoclonal bands in the cerebrospinal fluid of patients with endemic tropical spastic paraparesis. J Infect Dis. 1988 Jun;157(6):1226–1234. doi: 10.1093/infdis/157.6.1226. [DOI] [PubMed] [Google Scholar]
  23. Gessain A., Gout O. Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I). Ann Intern Med. 1992 Dec 1;117(11):933–946. doi: 10.7326/0003-4819-117-11-933. [DOI] [PubMed] [Google Scholar]
  24. Gessain A., Saal F., Gout O., Daniel M. T., Flandrin G., de The G., Peries J., Sigaux F. High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis. Blood. 1990 Jan 15;75(2):428–433. [PubMed] [Google Scholar]
  25. Giraudon P., Vernant J. C., Confavreux C., Belin M. F., Desgranges C. Matrix metalloproteinase 9 (gelatinase B) in cerebrospinal fluid of HTLV-1 infected patients with tropical spastic paraparesis. Neurology. 1998 Jun;50(6):1920–1920. doi: 10.1212/wnl.50.6.1920. [DOI] [PubMed] [Google Scholar]
  26. Godoy A. J., Kira J., Hasuo K., Goto I. Characterization of cerebral white matter lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis in comparison with multiple sclerosis and collagen-vasculitis: a semiquantitative MRI study. J Neurol Sci. 1995 Nov;133(1-2):102–111. doi: 10.1016/0022-510x(95)00161-t. [DOI] [PubMed] [Google Scholar]
  27. Grant A. D., Djomand G., Smets P., Kadio A., Coulibaly M., Kakou A., Maurice C., Whitaker J. P., Sylla-Koko F., Bonard D. Profound immunosuppression across the spectrum of opportunistic disease among hospitalized HIV-infected adults in Abidjan, Côte d'Ivoire. AIDS. 1997 Sep;11(11):1357–1364. doi: 10.1097/00002030-199711000-00010. [DOI] [PubMed] [Google Scholar]
  28. Greenberg A. E., Nguyen-Dinh P., Mann J. M., Kabote N., Colebunders R. L., Francis H., Quinn T. C., Baudoux P., Lyamba B., Davachi F. The association between malaria, blood transfusions, and HIV seropositivity in a pediatric population in Kinshasa, Zaire. JAMA. 1988 Jan 22;259(4):545–549. [PubMed] [Google Scholar]
  29. Greten T. F., Slansky J. E., Kubota R., Soldan S. S., Jaffee E. M., Leist T. P., Pardoll D. M., Jacobson S., Schneck J. P. Direct visualization of antigen-specific T cells: HTLV-1 Tax11-19- specific CD8(+) T cells are activated in peripheral blood and accumulate in cerebrospinal fluid from HAM/TSP patients. Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7568–7573. doi: 10.1073/pnas.95.13.7568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Hatae T., Hara H., Kobayashi T., Watanabe T. The effect of rolipram on the production of cytokines in HTLV-I infected cell lines and peripheral blood mononuclear cells of patients with HTLV-I-associated myelopathy (HAM). J Neurol Sci. 1997 May 1;148(1):87–94. doi: 10.1016/s0022-510x(96)05337-3. [DOI] [PubMed] [Google Scholar]
  31. Heyderman R. S., Gangaidzo I. T., Hakim J. G., Mielke J., Taziwa A., Musvaire P., Robertson V. J., Mason P. R. Cryptococcal meningitis in human immunodeficiency virus-infected patients in Harare, Zimbabwe. Clin Infect Dis. 1998 Feb;26(2):284–289. doi: 10.1086/516298. [DOI] [PubMed] [Google Scholar]
  32. Hopewell P. C. Impact of human immunodeficiency virus infection on the epidemiology, clinical features, management, and control of tuberculosis. Clin Infect Dis. 1992 Sep;15(3):540–547. doi: 10.1093/clind/15.3.540. [DOI] [PubMed] [Google Scholar]
  33. Howlett W. P., Nkya W. M., Mmuni K. A., Missalek W. R. Neurological disorders in AIDS and HIV disease in the northern zone of Tanzania. AIDS. 1989 May;3(5):289–296. doi: 10.1097/00002030-198905000-00007. [DOI] [PubMed] [Google Scholar]
  34. Höllsberg P., Batra V., Dressel A., Hafler D. A. Induction of anergy in CD8 T cells by B cell presentation of antigen. J Immunol. 1996 Dec 15;157(12):5269–5276. [PubMed] [Google Scholar]
  35. Höllsberg P. Pathogenesis of chronic progressive myelopathy associated with human T-cell lymphotropic virus type I. Acta Neurol Scand Suppl. 1997;169:86–93. doi: 10.1111/j.1600-0404.1997.tb08156.x. [DOI] [PubMed] [Google Scholar]
  36. Imwidthaya P. One year's experience with Cryptococcus neoformans in Thailand. Trans R Soc Trop Med Hyg. 1994 Mar-Apr;88(2):208–208. doi: 10.1016/0035-9203(94)90300-x. [DOI] [PubMed] [Google Scholar]
  37. Kahn J. O., Walker B. D. Acute human immunodeficiency virus type 1 infection. N Engl J Med. 1998 Jul 2;339(1):33–39. doi: 10.1056/NEJM199807023390107. [DOI] [PubMed] [Google Scholar]
  38. Kaplan J. E., Hu D. J., Holmes K. K., Jaffe H. W., Masur H., De Cock K. M. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world. Am J Trop Med Hyg. 1996 Jul;55(1):1–11. [PubMed] [Google Scholar]
  39. Kataoka A., Imai H., Inayoshi S., Tsuda T. Intermittent high-dose vitamin C therapy in patients with HTLV-I associated myelopathy. J Neurol Neurosurg Psychiatry. 1993 Nov;56(11):1213–1216. doi: 10.1136/jnnp.56.11.1213. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Khanna N., Chandramuki A., Desai A., Ravi V. Cryptococcal infections of the central nervous system: an analysis of predisposing factors, laboratory findings and outcome in patients from South India with special reference to HIV infection. J Med Microbiol. 1996 Nov;45(5):376–379. doi: 10.1099/00222615-45-5-376. [DOI] [PubMed] [Google Scholar]
  41. Kira J., Itoyama Y., Koyanagi Y., Tateishi J., Kishikawa M., Akizuki S., Kobayashi I., Toki N., Sueishi K., Sato H. Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I-associated myelopathy. Ann Neurol. 1992 Jan;31(1):39–45. doi: 10.1002/ana.410310108. [DOI] [PubMed] [Google Scholar]
  42. Kitze B., Usuku K., Izumo S., Nakamura M., Shiraki H., Ijichi S., Yashiki S., Fujiyoshi T., Sonoda S., Osame M. Diversity of intrathecal antibody synthesis against HTLV-I and its relation to HTLV-I associated myelopathy. J Neurol. 1996 May;243(5):393–400. doi: 10.1007/BF00868998. [DOI] [PubMed] [Google Scholar]
  43. Krämer A., Maloney E. M., Morgan O. S., Rodgers-Johnson P., Manns A., Murphy E. L., Larsen S., Cranston B., Murphy J., Benichou J. Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica. Am J Epidemiol. 1995 Dec 1;142(11):1212–1220. doi: 10.1093/oxfordjournals.aje.a117580. [DOI] [PubMed] [Google Scholar]
  44. Kure K., Llena J. F., Lyman W. D., Soeiro R., Weidenheim K. M., Hirano A., Dickson D. W. Human immunodeficiency virus-1 infection of the nervous system: an autopsy study of 268 adult, pediatric, and fetal brains. Hum Pathol. 1991 Jul;22(7):700–710. doi: 10.1016/0046-8177(91)90293-x. [DOI] [PubMed] [Google Scholar]
  45. Kuroda Y., Matsui M. Cerebrospinal fluid interferon-gamma is increased in HTLV-I-associated myelopathy. J Neuroimmunol. 1993 Feb;42(2):223–226. doi: 10.1016/0165-5728(93)90014-p. [DOI] [PubMed] [Google Scholar]
  46. Kuroda Y., Yukitake M., Kurohara K., Takashima H., Matsui M. A follow-up study on spastic paraparesis in Japanese HAM/TSP. J Neurol Sci. 1995 Oct;132(2):174–176. doi: 10.1016/0022-510x(95)00142-o. [DOI] [PubMed] [Google Scholar]
  47. Lambert G., Thea D. M., Pliner V., Steketee R. W., Abrams E. J., Matheson P., Thomas P. A., Greenberg B., Brown T. M., Bamji M. Effect of maternal CD4+ cell count, acquired immunodeficiency syndrome, and viral load on disease progression in infants with perinatally acquired human immunodeficiency virus type 1 infection. New York City Perinatal HIV Transmission Collaborative Study Group. J Pediatr. 1997 Jun;130(6):890–897. doi: 10.1016/s0022-3476(97)70274-9. [DOI] [PubMed] [Google Scholar]
  48. Lane H. C., Laughon B. E., Falloon J., Kovacs J. A., Davey R. T., Jr, Polis M. A., Masur H. NIH conference. Recent advances in the management of AIDS-related opportunistic infections. Ann Intern Med. 1994 Jun 1;120(11):945–955. doi: 10.7326/0003-4819-120-11-199406010-00007. [DOI] [PubMed] [Google Scholar]
  49. Lanjewar D. N., Jain P. P., Shetty C. R. Profile of central nervous system pathology in patients with AIDS: an autopsy study from India. AIDS. 1998 Feb 12;12(3):309–313. doi: 10.1097/00002030-199803000-00009. [DOI] [PubMed] [Google Scholar]
  50. Law A., Wallis S. C., Powell L. M., Pease R. J., Brunt H., Priestley L. M., Knott T. J., Scott J., Altman D. G., Miller G. J. Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet. 1986 Jun 7;1(8493):1301–1303. doi: 10.1016/s0140-6736(86)91222-5. [DOI] [PubMed] [Google Scholar]
  51. Lehky T. J., Fox C. H., Koenig S., Levin M. C., Flerlage N., Izumo S., Sato E., Raine C. S., Osame M., Jacobson S. Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization. Ann Neurol. 1995 Feb;37(2):167–175. doi: 10.1002/ana.410370206. [DOI] [PubMed] [Google Scholar]
  52. Leport C., Raffi F., Matheron S., Katlama C., Regnier B., Saimot A. G., Marche C., Vedrenne C., Vilde J. L. Treatment of central nervous system toxoplasmosis with pyrimethamine/sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome. Efficacy of long-term continuous therapy. Am J Med. 1988 Jan;84(1):94–100. doi: 10.1016/0002-9343(88)90014-9. [DOI] [PubMed] [Google Scholar]
  53. Levy R. M., Janssen R. S., Bush T. J., Rosenblum M. L. Neuroepidemiology of acquired immunodeficiency syndrome. J Acquir Immune Defic Syndr. 1988;1(1):31–40. [PubMed] [Google Scholar]
  54. Lobato M. N., Caldwell M. B., Ng P., Oxtoby M. J. Encephalopathy in children with perinatally acquired human immunodeficiency virus infection. Pediatric Spectrum of Disease Clinical Consortium. J Pediatr. 1995 May;126(5 Pt 1):710–715. doi: 10.1016/s0022-3476(95)70397-7. [DOI] [PubMed] [Google Scholar]
  55. Lucas S. B., Hounnou A., Peacock C., Beaumel A., Djomand G., N'Gbichi J. M., Yeboue K., Hondé M., Diomande M., Giordano C. The mortality and pathology of HIV infection in a west African city. AIDS. 1993 Dec;7(12):1569–1579. doi: 10.1097/00002030-199312000-00005. [DOI] [PubMed] [Google Scholar]
  56. Luft B. J., Remington J. S. Toxoplasmic encephalitis in AIDS. Clin Infect Dis. 1992 Aug;15(2):211–222. doi: 10.1093/clinids/15.2.211. [DOI] [PubMed] [Google Scholar]
  57. Maher D., Mwandumba H. Cryptococcal meningitis in Lilongwe and Blantyre, Malawi. J Infect. 1994 Jan;28(1):59–64. doi: 10.1016/s0163-4453(94)94161-0. [DOI] [PubMed] [Google Scholar]
  58. Matthiessen L., Marche C., Labrousse F., Trophilme D., Fontaine C., Vedrenne C. Etude neuropathologique de l'encéphale de 174 patients morts du SIDA dans un hôpital parisien, de 1982 à 1988. Ann Med Interne (Paris) 1992;143(1):43–49. [PubMed] [Google Scholar]
  59. Mayanja-Kizza H., Oishi K., Mitarai S., Yamashita H., Nalongo K., Watanabe K., Izumi T., Ococi-Jungala, Augustine K., Mugerwa R. Combination therapy with fluconazole and flucytosine for cryptococcal meningitis in Ugandan patients with AIDS. Clin Infect Dis. 1998 Jun;26(6):1362–1366. doi: 10.1086/516372. [DOI] [PubMed] [Google Scholar]
  60. Merle H., Smadja D., Le Hoang P., Bera O., Cabre P., Landau M., Vernant J. C. Ocular manifestations in patients with HTLV-I associated infection--a clinical study of 93 cases. Jpn J Ophthalmol. 1996;40(2):260–270. [PubMed] [Google Scholar]
  61. Mohar A., Romo J., Salido F., Jessurun J., Ponce de León S., Reyes E., Volkow P., Larraza O., Peredo M. A., Cano C. The spectrum of clinical and pathological manifestations of AIDS in a consecutive series of autopsied patients in Mexico. AIDS. 1992 May;6(5):467–473. doi: 10.1097/00002030-199205000-00005. [DOI] [PubMed] [Google Scholar]
  62. Moritoyo H., Arimura K., Arimura Y., Tokimura Y., Rosales R., Osame M. Study of lower limb somatosensory evoked potentials in 96 cases of HTLV-I-associated myelopathy/tropical spastic paraparesis. J Neurol Sci. 1996 Jun;138(1-2):78–81. doi: 10.1016/0022-510x(95)00351-2. [DOI] [PubMed] [Google Scholar]
  63. Moritoyo T., Reinhart T. A., Moritoyo H., Sato E., Izumo S., Osame M., Haase A. T. Human T-lymphotropic virus type I-associated myelopathy and tax gene expression in CD4+ T lymphocytes. Ann Neurol. 1996 Jul;40(1):84–90. doi: 10.1002/ana.410400114. [DOI] [PubMed] [Google Scholar]
  64. Mouton Y., Alfandari S., Valette M., Cartier F., Dellamonica P., Humbert G., Lang J. M., Massip P., Mechali D., Leclercq P. Impact of protease inhibitors on AIDS-defining events and hospitalizations in 10 French AIDS reference centres. Fédération National des Centres de Lutte contre le SIDA. AIDS. 1997 Oct;11(12):F101–F105. doi: 10.1097/00002030-199712000-00003. [DOI] [PubMed] [Google Scholar]
  65. Msellati P., Lepage P., Hitimana D. G., Van Goethem C., Van de Perre P., Dabis F. Neurodevelopmental testing of children born to human immunodeficiency virus type 1 seropositive and seronegative mothers: a prospective cohort study in Kigali, Rwanda. Pediatrics. 1993 Dec;92(6):843–848. [PubMed] [Google Scholar]
  66. Murray C. J., Styblo K., Rouillon A. Tuberculosis in developing countries: burden, intervention and cost. Bull Int Union Tuberc Lung Dis. 1990 Mar;65(1):6–24. [PubMed] [Google Scholar]
  67. Nakagawa M., Nakahara K., Maruyama Y., Kawabata M., Higuchi I., Kubota H., Izumo S., Arimura K., Osame M. Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis. J Neurovirol. 1996 Oct;2(5):345–355. doi: 10.3109/13550289609146899. [DOI] [PubMed] [Google Scholar]
  68. Oger J. J., Werker D. H., Foti D. J., Dekaban G. A. HTLV-I associated myelopathy: an endemic disease of Canadian aboriginals of the Northwest Pacific coast? Can J Neurol Sci. 1993 Nov;20(4):302–306. [PubMed] [Google Scholar]
  69. Osame M., Matsumoto M., Usuku K., Izumo S., Ijichi N., Amitani H., Tara M., Igata A. Chronic progressive myelopathy associated with elevated antibodies to human T-lymphotropic virus type I and adult T-cell leukemialike cells. Ann Neurol. 1987 Feb;21(2):117–122. doi: 10.1002/ana.410210203. [DOI] [PubMed] [Google Scholar]
  70. Palella F. J., Jr, Delaney K. M., Moorman A. C., Loveless M. O., Fuhrer J., Satten G. A., Aschman D. J., Holmberg S. D. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998 Mar 26;338(13):853–860. doi: 10.1056/NEJM199803263381301. [DOI] [PubMed] [Google Scholar]
  71. Park Y. D., Belman A. L., Kim T. S., Kure K., Llena J. F., Lantos G., Bernstein L., Dickson D. W. Stroke in pediatric acquired immunodeficiency syndrome. Ann Neurol. 1990 Sep;28(3):303–311. doi: 10.1002/ana.410280302. [DOI] [PubMed] [Google Scholar]
  72. Perriëns J. H., Mussa M., Luabeya M. K., Kayembe K., Kapita B., Brown C., Piot P., Janssen R. Neurological complications of HIV-1-seropositive internal medicine inpatients in Kinshasa, Zaire. J Acquir Immune Defic Syndr. 1992;5(4):333–340. [PubMed] [Google Scholar]
  73. Porter S. B., Sande M. A. Toxoplasmosis of the central nervous system in the acquired immunodeficiency syndrome. N Engl J Med. 1992 Dec 3;327(23):1643–1648. doi: 10.1056/NEJM199212033272306. [DOI] [PubMed] [Google Scholar]
  74. Powderly W. G. Cryptococcal meningitis and AIDS. Clin Infect Dis. 1993 Nov;17(5):837–842. doi: 10.1093/clinids/17.5.837. [DOI] [PubMed] [Google Scholar]
  75. Powderly W. G., Saag M. S., Cloud G. A., Robinson P., Meyer R. D., Jacobson J. M., Graybill J. R., Sugar A. M., McAuliffe V. J., Follansbee S. E. A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. The NIAID AIDS Clinical Trials Group and Mycoses Study Group. N Engl J Med. 1992 Mar 19;326(12):793–798. doi: 10.1056/NEJM199203193261203. [DOI] [PubMed] [Google Scholar]
  76. Power C., Nath A., Aoki F. Y., Bigio M. D. Remission of progressive multifocal leukoencephalopathy following splenectomy and antiretroviral therapy in a patient with HIV infection. N Engl J Med. 1997 Feb 27;336(9):661–662. doi: 10.1056/NEJM199702273360914. [DOI] [PubMed] [Google Scholar]
  77. Price R. W. Neurological complications of HIV infection. Lancet. 1996 Aug 17;348(9025):445–452. doi: 10.1016/S0140-6736(95)11035-6. [DOI] [PubMed] [Google Scholar]
  78. Richards F. O., Jr, Kovacs J. A., Luft B. J. Preventing toxoplasmic encephalitis in persons infected with human immunodeficiency virus. Clin Infect Dis. 1995 Aug;21 (Suppl 1):S49–S56. doi: 10.1093/clinids/21.supplement_1.s49. [DOI] [PubMed] [Google Scholar]
  79. Rodgers-Johnson P. E. Tropical spastic paraparesis/HTLV-I associated myelopathy. Etiology and clinical spectrum. Mol Neurobiol. 1994 Apr-Jun;8(2-3):175–179. doi: 10.1007/BF02780668. [DOI] [PubMed] [Google Scholar]
  80. Rosemberg S., Lopes M. B., Tsanaclis A. M. Neuropathology of acquired immunodeficiency syndrome (AIDS). Analysis of 22 Brazilian cases. J Neurol Sci. 1986 Dec;76(2-3):187–198. doi: 10.1016/0022-510x(86)90168-1. [DOI] [PubMed] [Google Scholar]
  81. Rozenbaum R., Gonçalves A. J. Clinical epidemiological study of 171 cases of cryptococcosis. Clin Infect Dis. 1994 Mar;18(3):369–380. doi: 10.1093/clinids/18.3.369. [DOI] [PubMed] [Google Scholar]
  82. Saag M. S., Powderly W. G., Cloud G. A., Robinson P., Grieco M. H., Sharkey P. K., Thompson S. E., Sugar A. M., Tuazon C. U., Fisher J. F. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group. N Engl J Med. 1992 Jan 9;326(2):83–89. doi: 10.1056/NEJM199201093260202. [DOI] [PubMed] [Google Scholar]
  83. Santosh V., Shankar S. K., Das S., Pal L., Ravi V., Desai A., Sreedharan A., Khanna N., Chandramuki A., Satishchandra P. Pathological lesions in HIV positive patients. Indian J Med Res. 1995 Apr;101:134–141. [PubMed] [Google Scholar]
  84. Shafer R. W., Edlin B. R. Tuberculosis in patients infected with human immunodeficiency virus: perspective on the past decade. Clin Infect Dis. 1996 Apr;22(4):683–704. doi: 10.1093/clinids/22.4.683. [DOI] [PubMed] [Google Scholar]
  85. Smadja D., Bellance R., Cabre P., Arfi S., Vernant J. C. Clinical characteristics of HTLV-1 associated dermato-polymyositis. Seven cases from Martinique. Acta Neurol Scand. 1995 Sep;92(3):206–212. doi: 10.1111/j.1600-0404.1995.tb01689.x. [DOI] [PubMed] [Google Scholar]
  86. Smadja D., Fournerie P., Cabre P., Cabie A., Olindo S. Efficacité et bonne tolérance du cotrimoxazole comme traitement de la toxoplasmose cérébrale au cours du SIDA. Presse Med. 1998 Sep 12;27(26):1315–1320. [PubMed] [Google Scholar]
  87. Small P. M., Schecter G. F., Goodman P. C., Sande M. A., Chaisson R. E., Hopewell P. C. Treatment of tuberculosis in patients with advanced human immunodeficiency virus infection. N Engl J Med. 1991 Jan 31;324(5):289–294. doi: 10.1056/NEJM199101313240503. [DOI] [PubMed] [Google Scholar]
  88. Swinne D., Deppner M., Laroche R., Floch J. J., Kadende P. Isolation of Cryptococcus neoformans from houses of AIDS-associated cryptococcosis patients in Bujumbura (Burundi). AIDS. 1989 Jun;3(6):389–390. doi: 10.1097/00002030-198906000-00009. [DOI] [PubMed] [Google Scholar]
  89. Tangy F., Vernant J. C., Coscoy L., Ossondo M., Bellance R., Zaninovic V., Cartier L., Brahic M., Ozden S. A search for human T-cell leukemia virus type I in the lesions of patients with tropical spastic paraparesis and polymyositis. Ann Neurol. 1995 Sep;38(3):454–460. doi: 10.1002/ana.410380317. [DOI] [PubMed] [Google Scholar]
  90. Trujillo J. R., Garcìa-Ramos G., Novak I. S., Rivera V. M., Huerta E., Essex M. Neurologic manifestations of AIDS: a comparative study of two populations from Mexico and the United States. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jan 1;8(1):23–29. [PubMed] [Google Scholar]
  91. Umehara F., Izumo S., Nakagawa M., Ronquillo A. T., Takahashi K., Matsumuro K., Sato E., Osame M. Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol. 1993 Jul;52(4):424–430. doi: 10.1097/00005072-199307000-00010. [DOI] [PubMed] [Google Scholar]
  92. Umehara F., Izumo S., Ronquillo A. T., Matsumuro K., Sato E., Osame M. Cytokine expression in the spinal cord lesions in HTLV-I-associated myelopathy. J Neuropathol Exp Neurol. 1994 Jan;53(1):72–77. doi: 10.1097/00005072-199401000-00009. [DOI] [PubMed] [Google Scholar]
  93. Umehara F., Nakamura A., Izumo S., Kubota R., Ijichi S., Kashio N., Hashimoto K., Usuku K., Sato E., Osame M. Apoptosis of T lymphocytes in the spinal cord lesions in HTLV-I-associated myelopathy: a possible mechanism to control viral infection in the central nervous system. J Neuropathol Exp Neurol. 1994 Nov;53(6):617–624. doi: 10.1097/00005072-199411000-00009. [DOI] [PubMed] [Google Scholar]
  94. Vernant J. C., Buisson G., Magdeleine J., De Thore J., Jouannelle A., Neisson-Vernant C., Monplaisir N. T-lymphocyte alveolitis, tropical spastic paresis, and Sjögren syndrome. Lancet. 1988 Jan 23;1(8578):177–177. doi: 10.1016/s0140-6736(88)92744-4. [DOI] [PubMed] [Google Scholar]
  95. Vernant J. C., Maurs L., Gessain A., Barin F., Gout O., Delaporte J. M., Sanhadji K., Buisson G., de-Thé G. Endemic tropical spastic paraparesis associated with human T-lymphotropic virus type I: a clinical and seroepidemiological study of 25 cases. Ann Neurol. 1987 Feb;21(2):123–130. doi: 10.1002/ana.410210204. [DOI] [PubMed] [Google Scholar]
  96. van der Horst C. M., Saag M. S., Cloud G. A., Hamill R. J., Graybill J. R., Sobel J. D., Johnson P. C., Tuazon C. U., Kerkering T., Moskovitz B. L. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. National Institute of Allergy and Infectious Diseases Mycoses Study Group and AIDS Clinical Trials Group. N Engl J Med. 1997 Jul 3;337(1):15–21. doi: 10.1056/NEJM199707033370103. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

[Correction to Table 2]
jnnpsyc_68_5_550__index.html (1.3KB, html)
jnnpsyc_68_5_550__1.html (3.6KB, html)

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES